Risk Minimisation Materials

Abacavir - Patient Alert Card

Patient alert card for medicines containing Abacavir. This patient alert card should be used by patients who have been prescribed medicines containing Abacavir' and should carry with them at all times when taking this medicine.

For Healthcare Professionals

Abacavir alert card

Patient Alert Card

For Healthcare Professionals

Abacavir Alert Card

Important - Alert Card for Medicines Containing Abacavir.

Abacavir Brochure Risk Minimisation - Hypersensitivity Reaction

Key Risk Minimisation Points - Abacavir Hypersensitivity Reaction; prevention and diagnosis of hypersensitivity reaction.

For Healthcare Professionals

Abacavir Hypersensitivity Educational Slides for Healthcare Professionals

Abacavir Hypersensitivity Educational Slides for Healthcare Professionals

For Healthcare Professionals

Abacavir Patient Alert Card

Abacavir Patient Alert Card

Abacavir / Lamivudine Patient Alert Card

Patient Alert Card for Medicines Containing Abacavir

Hypersensitivity Reactions to Abacavir / Lamivudine educational material

Educational materials for Healthcare Professionals for Abacavir Hypersensitivity Reaction (HSR)

For Healthcare Professionals

Abacavir Alert Card

Important - Alert Card for Medicines Containing Abacavir.

Abacavir Brochure Risk Minimisation - Hypersensitivity Reaction

Key Risk Minimisation Points - Abacavir Hypersensitivity Reaction; prevention and diagnosis of hypersensitivity reaction.

For Healthcare Professionals

Abacavir Alert Card

Alert Card for Medicines Containing Abacavir

Abacavir alert card

Patient Alert Card

For Healthcare Professionals

Abacavir -Risk minimisation Brochure

Abacavir hypersensitivity reaction Key risk minimisation points: Abacavir Hypersensitivity Reaction (HSR)

For Healthcare Professionals

Abacavir/Lamivudine 600 mg/300 mg film-coated tablets

Patient Alert Card

Educational material

Abacavir brochure risk minimisation

For Healthcare Professionals

Patient alert card

Abacavir patient alert card

Abstral Patient and Carer Guide

Abstral (fentanyl citrate) sublingual tablets - Important risk minimisation information for patients and their carers

Abstral Patient and Carer Guide

Abstral (fentanyl citrate) sublingual tablets - Important risk minimisation information for patients and their carers

Abstral Prescriber Guide

Abstral (fentanyl citrate) sublingual tablets - Important risk minimisation information for healthcare professionals

For Healthcare Professionals

Abstral Prescriber Guide

Abstral (fentanyl citrate) sublingual tablets - Important risk minimisation information for healthcare professionals

For Healthcare Professionals

Patient Alert Card

Alert card to be distributed to all patients (male and female) each time the product is prescribed as a reminder of the required pregnancy prevention requirements/considerations.

Pharmacist Checklist - Guidance for dispensing Acitretin

Guidance document for pharmacists including a background on the risks in addition to a list of information to be confirmed with the patient prior to dispensing.

For Healthcare Professionals

'Prescriber Checklist/Acknowledgement Form for Prescribing Acitretin to Female Patients

Guidance document for pharmacists including a background on the risks in addition to a list of information to be confirmed with the patient prior to dispensing.

Patient Reminder Card

Alert card to be distributed to all patients (male and female) receiving acitretin each time the product is prescribed as a reminder of the required pregnancy prevention requirements/considerations.

For Healthcare Professionals

Pharmacist Checklist - Guidance for Dispensing Acitretin

Guidance document for pharmacists including a background on the risks of acitretin in addition to a list of information to be confirmed with the patient prior to dispensing.

For Healthcare Professionals

Prescriber Checklist / Acknowledgement Form for Prescribing Acitretin to Female Patients

Checklist/acknowledgement form for use when prescribing acitretin to female patients. This is intended to support discussion with the patient, present the key principles of the PPP and record that discussions have taken place by recording patient and prescriber signatures.

For Healthcare Professionals

Guide For Healthcare Professionals - Important Risk Minimisation Information on Potential Risk of Medication Errors

Guide For Healthcare Professionals - Important Risk Minimisation Information on Potential Risk of Medication Errors

For Healthcare Professionals

Patient Guide for Actiq® (fentanyl citrate) Lozenges

Patient Guide For Actiq® (fentanyl citrate) Lozenges

Patient Treatment Diary for Actiq® (fentanyl citrate) Lozenge

This Treatment Diary is designed to help you monitor your experience of BTcP and your use of Actiq®. It will give you and your doctor a valuable insight into your progress and ensure you are receiving the correct level of treatment

Prescription Guide for Healthcare Professionals for Actiq (fentanyl citrate) Lozenge

This guide is designed to provide information around the use of Actiq® (fentanyl citrate) lozenges for Healthcare Professionals (HCPs). More specifically, identifying appropriate patients and correctly prescribing Actiq® to minimise the risk of misuse/pharmacodependence, abuse, medication errors, drug diversion, accidental exposure, overdose, off-label use, respiratory depression and local tolerability (dental decay) in patients not receiving opioid background therapy.

For Healthcare Professionals

ADHD Introduction

Attention-deficit/hyperactivity disorder (ADHD) physician’s guide to prescribing Introduction

For Healthcare Professionals

Chart for ongoing monitoring

Chart for ongoing monitoring during methylphenidate (MPH) treatment

For Healthcare Professionals

Checklist 1: Methylphenidate (MPH) checklist before prescribing

Checklist 1: Methylphenidate (MPH) checklist before prescribing

For Healthcare Professionals

Checklist 2: Methylphenidate (MPH) checklist for ongoing monitoring

Checklist 2: Methylphenidate (MPH) checklist for ongoing monitoring

For Healthcare Professionals

Agomelatine Flow Chart

Liver function monitoring scheme with Agomelatine for the treatment of major depressive episodes in adults

For Healthcare Professionals

Agomelatine patient information guide

Important information for patients about Agomelatine-recommendations to avoid liver side effects

For Healthcare Professionals

Agomelatine prescriber guide

Important safety information prescribers guide-Agomelatine- for the treatment of major depressive episodes in adults

For Healthcare Professionals

Liver Function Monitoring Scheme with Agomelatine

Liver function monitoring scheme with Agomelatine for the treatment of major depressive episodes in adults

For Healthcare Professionals

Patient information. Recommendations to avoid liver side effects

Important information for Patients about Agomelatine. Recommendations to avoid liver side effects

Prescribers Guide

Prescribers guide. Agomelatine for the treatment of Major Depressive Episodes in Adults

For Healthcare Professionals

Checklist for Prescribers - Akizza 75 mcg 20 mcg tablets

For Healthcare Professionals

Checklist for Prescribers - Akizza 75 mcg 30 mcg tablets

Please use this checklist in conjunction with the Summary of Product Characteristics during combined hormonal contraceptive (CHC) consultations

For Healthcare Professionals

Important Information Leaflet - Akizza 75mcg/20mcg Tablets

All women should understand the small risk of blood clots with the combined hormonal contraceptives; what other conditions increase the risk of a blood clot; the signs and symptoms of a blood clot; when you need to tell a healthcare professional that you are using a combined hormonal contraceptive.

Important Information leaflet - Akizza 75mcg/30mcg Tablets

All women should understand the small risk of blood clots with the combined hormonal contraceptives; what other conditions increase the risk of a blood clot; the signs and symptoms of a blood clot; when you need to tell a healthcare professional that you are using a combined hormonal contraceptive.

Patient Alert Card - Akizza 75mcg/20mcg Tablets

Important information for women about risk of blood clots with combined hormonal contraceptives.

Patient Alert Card - Akizza 75mcg/30mcg Tablets

Important information for women about risk of blood clots with combined hormonal contraceptives.

Alitretinoin Capsules Patient Reminder Card

To be given by the dermatologist, specialist dermatology nurses, or prescribing GP to reinforce the key safety messages around risks.

For Healthcare Professionals

Pharmacist Checklist and Guidance for Dispensing Alitretinoin Capsules

To be used by pharmacists when dispensing Alitretinoin 10mg & 30mg Capsules.

For Healthcare Professionals

Prescriber Checklist-Acknowledgement form for Prescribing Alitretinoin Capsules to Female patients

To be used by the dermatologist, specialist dermatology nurse, or a prescribing GP with a special interest in dermatology to record the discussion of risks with the patient when dispensing Alitretinoin 10mg & 30mg Capsules

For Healthcare Professionals

Rivastigmine Patch (Almuriva) - Instructions for use and patient diary - for patients

Instructions for use and patient diary

Alunbrig (brigatinib) Patient Alert Card

Patient Alert Card

Alzest instructions for use and patient diary Dec 2020

Instructions for use and patient diary

Ambrisentan Patient Reminder Card

Patient Reminder Card for Ambrisentan

For Healthcare Professionals

Ambrisentan patient reminder card

Ambrisentan patient reminder card

Ambrisentan Patient Reminder Cards

Key messages regarding the need for regular blood and pregnancy tests and provide spaces for the dates of appointments and the results of tests.

Patient Alert Card - Ambrisentan 5 & 10 mg tab

This card contains important information about Ambrisentan. Please read this card carefully before starting your treatment with Ambrisentan. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. If you are a woman of child-bearing age read this information carefully. Ambrisentan may harm unborn babies conceived before, during or soon after treatment. You must not take Ambrisentan if you are pregnant. Women of reproductive potential must use reliable contraception whilst taking Ambrisentan. Ambrisentan may cause liver injury. This card is produced as a service to patients by Cipla.

Patient Reminder Card

Important information for all patients taking Ambrisentan

Amfexa - Educational Risk Minimisation Materials to help reduce the risk with using this medicine.

HEALTHCARE PROFESSIONALS GUIDE TO PRESCRIBING WEBSITE Website to host materials for healthcare professionals to support appropriate prescribing of dexamfetamine sulphate

For Healthcare Professionals

AMGEVITA Patient reminder card - adult

This card has important safety information about AMGEVITA. To request a copy of the patient alert card please contact Amgen medical information on 01223 436441 or by email to [email protected]

AMGEVITA Patient reminder card - paediatric

This card has important safety information about AMGEVITA. To request a copy of the patient alert card please contact Amgen medical information on 01223 436441 or by email to [email protected]

Amglidia Prescriber Guide

Prescribing Information for HCP

For Healthcare Professionals

Amiodarone Alert card

Patient Alert Card

For Healthcare Professionals

Amiodarone Alert card

Patient Alert Card

For Healthcare Professionals

Apixaban Teva Patient Alert Card

Apixaban Teva Patient Alert Card

Apixaban Teva Prescriber Guide

Apixaban Teva Prescriber Guide

For Healthcare Professionals

Instructions for use for the Aranesp SureClick pre-filled pen

This booklet contains the instructions for use presented in a larger format and is intended for patients/caregivers with diminished eyesight. To request a printed version of this A4 booklet please contact Amgen Medical Information on 01223 436441 or by email to [email protected]

Training Checklist for Self Administration - Pre-Filled Pen (Sureclick)®

This checklist is designed to ensure the patient/caregiver has received sufficient training with a demonstration device to enable confident and competent self-administration of the Aranesp SureClick® pre-filled pen at home. To request a printed version of the Training Checklist please contact Amgen Medical Information on 01223 436441 or by email to [email protected]

For Healthcare Professionals

ARAVA- Physician leaflet

For hard copies please contact our medical information department at 0800 035 2525 or email [email protected]

For Healthcare Professionals

ARAVA-Patient Leaflet

For hard copies, please contact medical information department at 0800 035 2525 or email [email protected]

Arikayce Patient Alert Card

Patient alert card to notify patients on the adverse events and the procedure to deal with them.

Aronix - Pharmacy Checklist

a short guide to help pharmacists determine whether your patient is suitable for Aronix, or whether he should be seen by a doctor for further advice. Use of the checklist is optional, and pharmacists should use their professional judgement to decide when and how to use it.

For Healthcare Professionals

Essential information for the supply of Aronix

This document provides key information to facilitate the assessment as to whether to supply Aronix, it also provides information on erectile dysfunction, its causes, risk factors, co-morbid links,management, treatment options, Aronix product information and pharmacist role in supporting the man.

For Healthcare Professionals

Aubagio (teriflunomide) – Healthcare professional (HCP) – Education / Discussion Guide - Risk Minimisation Information for Healthcare Professionals

At first prescription, the prescriber/healthcare professional (HCP) should discuss with the patient the risks described within the discussion guide. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

For Healthcare Professionals

Aubagio (teriflunomide) – Patient Card - Risk Minimisation Information for Patients

The Patient Card contains important safety information the patient needs to be aware of when receiving treatment with Aubagio (teriflunomide). At first prescription, the prescriber/healthcare professional (HCP) should provide the Patient Card. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]